bioRxivBiophysicsPreprint
Multi-parameter formulation development for an HIV-vaccine protein with direct validation of epitope binding integrity and stoichiometry
C. Popp, P. Schramm, R. Wagner, D. Peterhoff, C. Battle, C. Kleusch, M. G. Plach
Abstract
Vaccines are on the front line-of-defense against infectious diseases, ranging from threats we are familiar with, including polio, tuberculosis, or HIV, to novel and emerging threats such as SARS-CoV-2. Successful development of new protein-based vaccines requires sophisticated and efficient development of storage and formulation conditions. Here we demonstrate the combined power of 2binds sophisticated buffer matrix FORMOscreen(R) and NanoTemper Technologies novel Prometheus Panta high-throughput Dynamic Light Scattering/Nano Differential Scanning Fluorimetry instrument. We show that this combination can comprehensively improve critical biophysical parameters for the HIV-1 vaccine BG505-SOSIP and find the optimal formulation condition with unmatched efficiency.
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- A VLP vaccine platform comprising the core protein of hepatitis B virus with N-terminal antigen capture
Kaniz Fatema, Joseph S. Snowden, … David J. Rowlands·International Journal of Biological MacromoleculesPeer-reviewed·Feb 15, 2025
- Virus-Like Particle Based-Vaccines Elicit Neutralizing Antibodies against the HIV-1 Fusion Peptide
A. T. Mogus, L. Liu, … B. Chackerian·bioRxiv·Sep 25, 2020
- Designed nanofiber immunogens prime antibody responsesto diverse conformations of the HIV-1 fusion peptide
Chelsea N. Fries, Jui-Lin Chen, … Joel H. Collier·bioRxiv·Oct 5, 2026
- Tailored Design of Protein Nanoparticle Scaffolds for Multivalent Presentation of Viral Glycoprotein Antigens
George Ueda, Aleksandar Antanasijevic, … David A. Baker·eLifePeer-reviewed·Aug 3, 2020
- Single-component multilayered self-assembling protein nanoparticles presenting glycan-trimmed uncleaved prefusion optimized envelope trimers as HIV-1 vaccine candidates
Y.-N. Zhang, J. Paynter, … J. Zhu·bioRxiv·Jul 1, 2022
- Elicitation of neutralizing antibody responses to HIV-1 immunization with nanoparticle vaccine platforms
A. A. Murji, J. S. Qin, … I. Georgiev·bioRxiv·Jun 3, 2021